Linus Pauling and Orthomolecular Medicine

Table of Contents

  1. Overview
  2. What the 1968 Paper Actually Argued
  3. From Psychiatry to Medicine
  4. The Mainstream Response
  5. What Mainstream Medicine Quietly Kept
  6. Orthomolecular Ideas Today
  7. Where Mainstream Medicine Agrees
  8. Where Mainstream Medicine Disagrees
  9. Key Research Papers
  10. Connections
  11. Featured Videos

1. Overview

In April 1968 the journal Science published a paper titled “Orthomolecular Psychiatry”, carrying the subtitle “Varying the concentrations of substances normally present in the human body may control mental disease.” Its author was Linus Pauling — then the world's most famous living chemist, and to this day the only person ever awarded two unshared Nobel Prizes (Chemistry in 1954, Peace in 1962). With that one paper, a 67-year-old giant of twentieth-century science coined a new word and launched a movement that is still with us: orthomolecular medicine, the idea that disease can be treated by adjusting the amounts of molecules the body already contains — vitamins, minerals, amino acids — rather than by introducing foreign drugs.

This page is about the theory itself and the word Pauling invented: what the 1968 paper actually argued, how “orthomolecular psychiatry” grew into “orthomolecular medicine,” how mainstream medicine answered, and which of the underlying ideas quietly survived inside conventional medicine under other names. Pauling's own attempts to apply the theory — vitamin C for colds, cancer, and heart disease — each have their own page and are only sketched here.

Why it matters to a reader today: nearly every modern claim about “optimizing” nutrient levels, megadose vitamin protocols, and individualized supplement regimens descends, directly or indirectly, from this one paper. Understanding what Pauling got right, what failed when tested, and how to tell the difference is one of the most useful skills a health-curious reader can own.

2. What the 1968 Paper Actually Argued

The word was built from the Greek orthos — “right” or “correct” — so “orthomolecular” literally means “the right molecules.” Pauling defined orthomolecular psychiatric therapy as “the treatment of mental disease by the provision of the optimum molecular environment for the mind, especially the optimum concentrations of substances normally present in the human body.” The emphasis on normally present was the whole point: not new drugs, but familiar molecules — niacin, vitamin C, B12 — at deliberately chosen, often very high, concentrations.

Pauling's opening move was to show that medicine already accepted the principle without naming it. The low-phenylalanine diet for phenylketonuria (PKU) prevents severe intellectual disability purely by varying the concentration of a substance normally present in the body — lowering phenylalanine instead of raising a vitamin, but the same logic. Insulin and thyroid hormone are likewise body-own molecules given to restore optimal concentrations. His proposal was to extend that accepted principle to the vitamins, at doses far above what prevents classical deficiency disease.

Three original arguments carried the paper:

Read half a century later, the paper is more careful than its reputation on either side suggests: it proposed mechanisms, cited what controlled evidence existed, and called for more research. It was not a supplement advertisement. But its load-bearing clinical evidence belonged to someone else, and the theory was published before that evidence had survived independent testing.

3. From Psychiatry to Medicine

The word did not stay confined to psychiatry for long. Within a few years Pauling and his colleagues were speaking of orthomolecular medicine: preserving health and treating disease of every kind by varying the concentrations of substances normally present in, and required by, the body. The ambition grew from “the optimum molecular environment for the mind” to the optimum molecular environment for everything.

A publishing ecosystem grew around the movement. Abram Hoffer had founded a journal in 1967; it passed through several names — including the Journal of Orthomolecular Psychiatry — before becoming today's Journal of Orthomolecular Medicine in 1986. One practical fact about that journal matters for readers: it is not indexed in MEDLINE, the National Library of Medicine's database behind PubMed. That is why searching PubMed for the movement's own flagship studies often turns up nothing — much of the orthomolecular literature circulates inside the movement's journals, reviewed by fellow believers rather than by outside specialists. Societies and annual conferences (today's International Society for Orthomolecular Medicine) complete the parallel infrastructure.

Pauling also built an institutional home: the institute he co-founded in 1973 became the Linus Pauling Institute of Science and Medicine, and — in a twist worth savoring — its successor, the Linus Pauling Institute at Oregon State University, is today a respected mainstream micronutrient research center whose Micronutrient Information Center is cited by clinicians who would never use the word “orthomolecular.”

The flagship application of the broadened theory was Pauling's own vitamin C program: gram doses for the common cold (his 1970 bestseller), then — with Scottish surgeon Ewan Cameron — 10 grams a day for terminal cancer patients, and late in life a vitamin C–plus–lysine theory of heart disease. Each of those stories, with its trials and rebuttals, is told on its own page: Vitamin C & Colds, Vitamin C & Cancer, and Heart Disease & Lysine.

4. The Mainstream Response

Psychiatry took the challenge seriously enough to answer formally. In 1973 the American Psychiatric Association published Task Force Report 7, Megavitamin and Orthomolecular Therapy in Psychiatry (a committee report chaired by Dr. Morris Lipton, not a journal paper), which reviewed the theory and the trial record. Its conclusions were blunt: the claims of megavitamin proponents had not been confirmed by independent research groups, and the report criticized the movement for promoting treatments to the public through books and press rather than through controlled studies — famously remarking that “the credibility of the megavitamin proponents is low.” Pauling fired back in a 1974 rebuttal in the American Journal of Psychiatry, arguing the task force had misread the theory and the trials; the exchange changed few minds on either side.

The marquee replication attempt was Wittenborn's long-term, randomized, double-blind trial of niacin in schizophrenia, published in 1973: it found no advantage for niacin over placebo. (Wittenborn later re-analyzed his data and suggested a small subgroup might have benefited — a lead that was never confirmed.) A series of collaborative Canadian trials run through the Canadian Mental Health Association under Thomas Ban and Heinz Lehmann likewise failed to reproduce the Saskatchewan results. The orthomolecular side answered that the replications used the wrong patients — chronic rather than acute cases — and tested niacin alone rather than the full protocol; critics answered that a claim which retreats to an ever-more-specific protocol whenever a trial fails has made itself untestable.

Why did the field never enter treatment guidelines for schizophrenia or anything else? Three reasons compounded. The central clinical claim failed independent replication — in evidence-based medicine, the near-fatal wound. The proposed mechanisms (the adrenochrome hypothesis behind the niacin trials, localized cerebral deficiency) were never validated, so there was no biological anchor to justify persisting. And the timing was unlucky: the same era handed psychiatry antipsychotic drugs with reproducible trial support, so the field consolidated around them. By about 1980 mainstream journals had largely stopped engaging with orthomolecular claims at all — which is why the debate today happens mostly in books, clinics, and the movement's own journals rather than in the indexed literature.

5. What Mainstream Medicine Quietly Kept

Here is the irony at the center of this story: the word stayed fringe, but several of the ideas underneath it became mainstream under other names. A fair accounting has to list them.

The pattern in every kept item is the same: a specific claim, tested in controlled trials, retained where it passed. What mainstream medicine discarded was not the idea that nutrients can treat disease — it was the leap from “sometimes, provably” to “generally, presumptively.”

6. Orthomolecular Ideas Today

The movement never disappeared; it changed clothes. Much of today's functional and integrative medicine is recognizably orthomolecular in inheritance: individualized nutrient testing, the language of “optimal” rather than merely “normal” levels, high-dose IV vitamin C clinics, and megadose B-vitamin protocols all trace their lineage to Pauling's paper and Hoffer's practice. The Journal of Orthomolecular Medicine still publishes, and orthomolecular societies still hold conferences. Meanwhile a more cautious academic descendant — nutritional psychiatry, which runs controlled trials of overall diet quality in depression and publishes in indexed journals — pursues the defensible core of the old intuition with modern methods and much more modest claims.

The fairest modern assessment of the founding claims comes from an unexpected source: L. John Hoffer — Abram Hoffer's son, a professor of medicine and clinical nutrition researcher — whose 2008 review of vitamin therapy in schizophrenia is sympathetic to what the pioneers attempted, frank that the burden of proof was never met, and precise about the ways the 1970s replications differed from the original protocols, leaving a few questions genuinely unresolved rather than cleanly refuted. It is the single best short read on the whole controversy, from someone with every reason to be fair to both sides.

How to read an orthomolecular claim — a checklist any reader can apply:

7. Where Mainstream Medicine Agrees

8. Where Mainstream Medicine Disagrees

9. Key Research Papers

  1. Pauling L. Orthomolecular psychiatry. Varying the concentrations of substances normally present in the human body may control mental disease. Science 1968;160(3825):265-71
  2. Pauling L, Itano HA, et al. Sickle cell anemia, a molecular disease. Science 1949;110(2865):543-8
  3. Hoffer A, Osmond H, Callbeck MJ, Kahan I. Treatment of schizophrenia with nicotinic acid and nicotinamide. J Clin Exp Psychopathol 1957;18(2):131-58
  4. Hoffer A, Osmond H. Treatment of schizophrenia with nicotinic acid. A ten year follow-up. Acta Psychiatr Scand 1964;40(2):171-89
  5. Wittenborn JR, Weber ES, Brown M. Niacin in the long-term treatment of schizophrenia. Arch Gen Psychiatry 1973;28(3):308-15
  6. Hoffer LJ. Vitamin therapy in schizophrenia. Isr J Psychiatry Relat Sci 2008;45(1):3-10
  7. American Psychiatric Association. Task Force Report 7: Megavitamin and Orthomolecular Therapy in Psychiatry. Washington, DC: APA; 1973. (Committee report, not PubMed-indexed.)

Live PubMed Searches

  1. Orthomolecular medicine
  2. Megavitamin therapy
  3. Niacin and schizophrenia
  4. Vitamin C and the common cold
  5. Vitamin-responsive inborn errors of metabolism

Connections

Back to Table of Contents